Viewing Study NCT06584435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-02-06 @ 3:07 AM
Study NCT ID: NCT06584435
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2024-09-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer
Sponsor: Tianjin Medical University Second Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High-risk Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-risk Renal Cell Carcinoma View
None Toripalimab View
None Adjuvant therapy View